Newsroom and media
Derivative coverage
India UK Pharma Trade Deal: Moving Beyond Tariff Reductions
A derivative adaptation of the five gate implementation argument, linked to its originating Pharmaceutical Technology commentary.
Historical source currently unavailable
The source is retained as a classified historical entry, but its publisher URL was unavailable at the latest review. No local copy is reproduced.
After publication
A trade deal is not a patient pathway
A trade agreement can change the commercial and policy context. The value depends on whether each implementation gate has evidence, ownership and a route to learning.
This is a later NEUVIOR founder reflection, not publisher copy or evidence of endorsement, adoption, deployment or outcomes.